Loading...
 
Home > Խ >
 
 
  2021 12 ġ α׷ 2022-02-11
 

 
 2022 ̳
 2021 11 ġ α׷
 
Ʈ
ۼ йȣ
 
 
 
, WilliamSEede (2026-03-31)
Zoya Demidenko: Scholar in Oncology Studies
Zoya Demidenko is a notable scientist connected with the Division of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Earlier, she conducted research at the NIH and New York Medical College, establishing a robust base in life science investigation.
Her academic output encompasses multiple pivotal domains, encompassing the PI3K/AKT/mTOR signaling pathway, cell cycle regulation, cellular aging, and malignancy biology. As of now, she has written more than 46 scientific publications, which have received upwards of 4,100 mentions a indicator to the influence of her findings.
Among her most significant contributions involves explaining the pathways of cellular senescence. Her research showed that when the cellular division cycle is halted but cellular expansion persists, the cells enter senescence. Significantly, Zoya Demidenko demonstrated that this transition is inhibited by medication using compounds such as mTOR inhibitors.
Zoya Demidenko has also brought greatly to oncological therapy investigation, particularly in the area of selective cell protection a strategy aimed at shielding non-cancerous cells from cytotoxic treatment whilst leaving cancer cells exposed. This approach offers considerable hope for reducing the adverse effects of oncological therapy.
Throughout her scientific life, Demidenko has collaborated with top researchers globally, such as Dr. Mikhail Blagosklonny. Her research appears in top-tier publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
<>1.03.2026 11:21] Ѭ: With an h-index of 33, Zoya Demidenko is recognized as a widely cited voice in contemporary cancer research, whose discoveries continue to shape our understanding of how biological cells age, interact with treatment, and how malignant disease may be more successfully combated.
https://www.instagram.com/zoyamonros/
 
 
 
, WilliamSEede (2026-03-31)
Zoya Demidenko: Scientist in Tumor Biology
Zoya Demidenko is a recognized scientist associated with the Department of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Previously, she conducted research at the National Institutes of Health and New York Medical College, establishing a strong foundation in life science investigation.
Her scholarly output spans a number of key areas, including the PI3K/AKT/mTOR signaling cascade, cell cycle regulation, biological aging, and tumor science. To date, she has co-authored over 46 peer-reviewed publications, which have received more than 4,100 references a indicator to the significance of her work.
Among her most notable contributions involves elucidating the mechanisms of cellular senescence. Her studies revealed that when the cell cycle is halted but cellular growth persists, cells enter senescence. Significantly, Zoya Demidenko established that this transition is inhibited by medication using agents such as rapamycin.
Zoya Demidenko has also added substantially to oncological therapy research, particularly in the area of cyclotherapy a strategy designed to safeguarding non-cancerous tissue from anticancer drugs whilst leaving tumor cells vulnerable. This strategy offers significant potential for diminishing the adverse effects of cancer treatment.
Across her scientific life, Demidenko has collaborated with leading researchers worldwide, including Dr. Mikhail Blagosklonny. Her publications appears in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
<>1.03.2026 11:21] Ѭ: Possessing an h-index of 33, Zoya Demidenko is recognized as a highly impactful voice in contemporary oncological science, with her findings continue to guide our comprehension of the way biological cells grow old, resist treatment, and how malignant disease may be better treated.
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED2C20LLC&SearchNameOrder=RAPAN20P050001591430&ListNameOrder=RAPAMED20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord
 
 
 
, DonPlay (2026-03-17)
֬, ܬѬܬڬ ݬ ֬Ѭݬ߬ ӬѬݬ ݬҬҬ ӬլѬӬѬݬ ԬݬѬӬ߬ ٬Ѭ߬ ڬԬѬ 2025 Ԭլ?
https://groups.google.com/u/5/g/topcasino_rus/c/k4CgRVc5d24
Ѭݬ֬Ѭ۬ Telegram-ܬѬ߬Ѭ @igaming_live ٬ ֬߬ ֬۬ڬ߬Ԭ -20 ѬӬެѬ, Ԭլ Ӭ֬֬߬߬ ڬ ܬѬڬӬ լ֬ݬѬݬ Ӭ ߬Ӭڬ߬ܬ!
https://t.me/s/iGaming_live
#ݬ #٬Ѭ߬ #ݬ #߬ݬѬ۬߬ܬѬ٬ڬ߬ #ݬڬ֬ݬ #igaming #ܬѬ٬ڬ߬ڬ #bigwin #pragmaticplay #hacksawgaming #ݬ2025 #Ѭ٬Ѭ߬֬ڬԬ #ܬѬ٬ڬ߬߬ݬѬ۬
 
 
 
, DonPlay (2026-03-16)
֬, ܬѬܬڬ ݬ ֬Ѭݬ߬ ӬѬݬ ݬҬҬ ӬլѬӬѬݬ ԬݬѬӬ߬ ٬Ѭ߬ ڬԬѬ 2025 Ԭլ?
Ѭݬ֬Ѭ۬ Telegram-ܬѬ߬Ѭ @igaming_live ٬ ֬߬ ֬۬ڬ߬Ԭ -20 ѬӬެѬ, Ԭլ Ӭ֬֬߬߬ ڬ ܬѬڬӬ լ֬ݬѬݬ Ӭ ߬Ӭڬ߬ܬ!
https://t.me/s/iGaming_live/4901
#ݬ #٬Ѭ߬ #ݬ #߬ݬѬ۬߬ܬѬ٬ڬ߬ #ݬڬ֬ݬ #igaming #ܬѬ٬ڬ߬ڬ #bigwin #pragmaticplay #hacksawgaming #ݬ2025 #Ѭ٬Ѭ߬֬ڬԬ #ܬѬ٬ڬ߬߬ݬѬ۬
 
 
 
, Richardkak (2026-03-15)

ڬ լѬݬ, լѬӬܬ ׬ܬѬ. ݬѬ!
٬ѬܬѬ٬Ѭ Ӭ֬ ެ
 
 
   11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 
 
 
 
개인정보 처리방침